← Open Payments lookup

MATTHEW BIEVER: Open Payments

NPI 1023227741 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,206 in 102 payments from 14 companies in 2025. Trend: 2023 $27,281 · 2024 $15,878 · 2025 $12,206

Speaker / faculty: $8,800Food & beverage: $1,706Honoraria: $1,700
CompanyPaymentsAmount
ABBVIE INC.20$8,976
Axsome Therapeutics, Inc.3$1,733
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$448
Otsuka America Pharmaceutical, Inc.17$299
Teva Pharmaceuticals USA, Inc.17$221
Alkermes, Inc.7$146
Janssen Pharmaceuticals, Inc4$106
Neurocrine BioSciences, Inc.5$100
Takeda Pharmaceuticals U.S.A., Inc.2$49
E.R. Squibb & Sons, L.L.C.2$32

Products named: VRAYLAR, Auvelity, CAPLYTA, ABILIFY ASIMTUFII, UZEDY, LYBALVI, INGREZZA, INVEGA SUSTENNA.

Industry payments across PA — which companies pay providers there.